Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T82393 | ||||
Target Name | TNF alpha converting enzyme (ADAM17) | ||||
Type of Target |
Clinical trial |
||||
Drug Potency against Target | DPC-333 | Drug Info | IC50 = 17~100 nM | [8] | |
2-(4-bromophenylsulfonamido)-N-hydroxyacetamide | Drug Info | IC50 = 3900 nM | [7] | ||
2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide | Drug Info | IC50 = 2400 nM | [7] | ||
Apratastat | Drug Info | IC50 = 140 nM | [1] | ||
CIPEMASTAT | Drug Info | Ki = 230 nM | [3] | ||
IK-862 | Drug Info | Ki = 0.56 nM | [5] | ||
N-hydroxy-2-(4-methoxyphenylsulfonamido)acetamide | Drug Info | IC50 = 1800 nM | [7] | ||
N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide | Drug Info | IC50 = 150 nM | [4] | ||
N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl) | Drug Info | IC50 = 110 nM | [4] | ||
PKF-241-466 | Drug Info | IC50 = 141 nM | [6] | ||
PKF-242-484 | Drug Info | IC50 = 56 nM | [6] | ||
SR-973 | Drug Info | Ki = 4 nM | [2] | ||
References | |||||
REF 1 | Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1605-9. | ||||
REF 2 | Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors. Bioorg Med Chem Lett. 2006 May 1;16(9):2357-63. | ||||
REF 3 | A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors. Bioorg Med Chem Lett. 2006 May 15;16(10):2632-6. | ||||
REF 4 | Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation. Bioorg Med Chem. 2008 Jan 1;16(1):530-5. | ||||
REF 5 | Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge. Bioorg Med Chem. 2008 Oct 1;16(19):8781-94. | ||||
REF 6 | Current perspective of TACE inhibitors: a review. Bioorg Med Chem. 2009 Jan 15;17(2):444-59. | ||||
REF 7 | Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule sheddi... J Med Chem. 2010 Mar 25;53(6):2622-35. | ||||
REF 8 | Characterization of [3H]apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard... J Pharmacol Toxicol Methods. 1996 Sep;36(1):53-62. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.